仙林AK47
Lv6
1735 积分
2022-03-03 加入
-
Cancer statistics, 2024
2个月前
已关闭
-
Cancer statistics, 2024
2个月前
已完结
-
Cancer incidence and mortality in China, 2022
2个月前
已完结
-
Cancer incidence and mortality in China, 2022
2个月前
已完结
-
Glofitamab for Relapsed or Refractory Diffuse Large B-Cell Lymphoma
3个月前
已完结
-
Long-term management of moderate-to-severe atopic dermatitis with dupilumab and concomitant topical corticosteroids (LIBERTY AD CHRONOS): a 1-year, randomised, double-blinded, placebo-controlled, phase 3 trial
3个月前
已完结
-
Long-term management of moderate-to-severe atopic dermatitis with dupilumab and concomitant topical corticosteroids (LIBERTY AD CHRONOS): a 1-year, randomised, double-blinded, placebo-controlled, phase 3 trial
3个月前
已完结
-
Efficacy and safety of CM310 in moderate-to-severe atopic dermatitis: A multicenter, randomized, double-blind, placebo-controlled phase 2b trial
3个月前
已关闭
-
Efficacy and safety of dupilumab in adults with moderate-to-severe atopic dermatitis inadequately controlled by topical treatments: a randomised, placebo-controlled, dose-ranging phase 2b trial
3个月前
已完结
-
Osimertinib with or without Chemotherapy in EGFR-Mutated Advanced NSCLC
3个月前
已完结